bf/NASDAQ:ALNY_icon.jpeg

COM:ALNYLAM

Alnylam Pharmaceuticals

  • Stock

Last Close

248.79

21/11 21:00

Market Cap

32.60B

Beta: -

Volume Today

676.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
47.17M
-
50.56M
7.20%
41.10M
18.72%
47.16M
14.75%
89.91M
90.66%
74.91M
16.69%
219.75M
193.36%
492.85M
124.28%
844.29M
71.31%
1.04B
22.88%
1.83B
76.23%
cost of revenue
1.80M
-
25.06M
1,290.79%
78.05M
211.44%
140.14M
79.55%
168.82M
20.46%
310.41M
83.87%
gross profit
47.17M
-
50.56M
7.20%
41.10M
18.72%
47.16M
14.75%
89.91M
90.66%
73.11M
18.69%
194.69M
166.31%
414.80M
113.06%
704.14M
69.75%
868.60M
23.36%
1.52B
74.75%
selling and marketing expenses
general and administrative expenses
27.15M
-
44.53M
63.99%
60.61M
36.12%
89.35M
47.42%
199.37M
123.12%
382.36M
91.79%
479.00M
25.28%
588.42M
22.84%
620.64M
5.48%
770.66M
24.17%
795.65M
3.24%
selling general and administrative expenses
27.15M
-
44.53M
63.99%
60.61M
36.12%
89.35M
47.42%
199.37M
123.12%
382.36M
91.79%
479.00M
25.28%
588.42M
22.84%
620.64M
5.48%
770.66M
24.17%
795.65M
3.24%
research and development expenses
112.96M
-
190.25M
68.43%
276.50M
45.33%
382.39M
38.30%
390.63M
2.16%
505.42M
29.38%
655.11M
29.62%
654.82M
0.05%
792.16M
20.97%
883.01M
11.47%
1.00B
13.75%
other expenses
-47K
-
1.82M
3,965.96%
76K
95.82%
6.17M
8,019.74%
-3.02M
148.97%
4.17M
238.09%
20.73M
396.76%
45.52M
119.61%
-2.05M
104.50%
-109.37M
5,234.98%
-17.74M
83.78%
cost and expenses
140.11M
-
234.78M
67.57%
337.11M
43.59%
471.75M
39.94%
590M
25.07%
889.58M
50.78%
1.16B
30.31%
1.32B
13.98%
1.55B
17.53%
1.82B
17.36%
2.11B
15.80%
operating expenses
140.11M
-
234.78M
67.57%
337.11M
43.59%
471.75M
39.94%
590M
25.07%
887.78M
50.47%
1.13B
27.75%
1.24B
9.62%
1.41B
13.64%
1.65B
17.05%
1.80B
8.85%
interest expense
1.07M
-
2.56M
139.38%
5.86M
128.96%
8.31M
41.80%
12.24M
47.28%
29.26M
139.15%
84.50M
-
143.02M
69.26%
155.97M
9.05%
121.22M
22.28%
ebitda
-92.94M
-
36.55M
139.33%
-296.01M
909.83%
-424.59M
43.44%
-500.09M
17.78%
-835.24M
67.02%
-939.43M
12.47%
-771.10M
17.92%
-709.12M
8.04%
-894.44M
26.13%
-228.12M
74.50%
operating income
-92.94M
-
-404.98M
335.73%
-296.01M
26.91%
-424.59M
43.44%
-500.09M
17.78%
-814.67M
62.91%
-939.43M
15.31%
-828.44M
11.81%
-708.65M
14.46%
-785.07M
10.78%
-282.18M
64.06%
depreciation and amortization
10.23M
-
11.93M
16.59%
19.05M
59.74%
15.13M
20.58%
13.37M
11.65%
6.43M
51.86%
54.37M
744.88%
57.33M
5.46%
-471K
100.82%
-109.37M
23,120.17%
54.05M
149.42%
total other income expenses net
-47K
-
-218.95M
465,748.94%
76K
100.03%
6.17M
8,019.74%
-3.02M
148.97%
24.74M
918.56%
54.18M
119.02%
-27.16M
150.13%
-143.49M
428.28%
-341.92M
138.29%
-151.34M
55.74%
income before tax
-91.92M
-
-400.60M
335.82%
-290.07M
27.59%
-410.11M
41.38%
-490.87M
19.69%
-760.67M
54.96%
-885.25M
16.38%
-855.60M
3.35%
-852.14M
0.40%
-1.13B
32.25%
-433.52M
61.53%
income tax expense
-2.69M
-
-40.21M
1,391.99%
-24.91M
38.05%
-23.44M
5.91%
-25.60M
9.24%
823K
103.21%
863K
4.86%
2.68M
210.66%
680K
74.64%
4.16M
512.21%
6.72M
61.54%
net income
-89.22M
-
-360.39M
303.92%
-290.07M
19.51%
-410.11M
41.38%
-490.87M
19.69%
-761.50M
55.13%
-886.12M
16.37%
-858.28M
3.14%
-852.82M
0.64%
-1.13B
32.64%
-440.24M
61.08%
weighted average shs out
61.55M
-
74.28M
20.68%
83.99M
13.08%
85.60M
1.91%
90.55M
5.79%
100.59M
11.08%
109.26M
8.62%
114.99M
5.24%
118.45M
3.01%
121.69M
2.73%
124.91M
2.64%
weighted average shs out dil
61.55M
-
74.28M
20.68%
83.99M
13.08%
85.60M
1.91%
90.55M
5.79%
100.59M
11.08%
109.26M
8.62%
114.99M
5.24%
118.45M
3.01%
121.69M
2.73%
124.91M
2.64%
eps
-1.45
-
-4.85
234.48%
-3.45
28.87%
-4.79
38.84%
-5.42
13.15%
-7.57
39.67%
-8.11
7.13%
-7.46
8.01%
-7.20
3.49%
-9.30
29.17%
-3.52
62.15%
epsdiluted
-1.45
-
-4.85
234.48%
-3.45
28.87%
-4.79
38.84%
-5.42
13.15%
-7.57
39.67%
-8.11
7.13%
-7.46
8.01%
-7.20
3.49%
-9.30
29.17%
-3.52
62.15%

All numbers in (except ratios and percentages)